Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus

References

• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) UK Prospective Diabetes Study (UKPDS) Group Lancet 1998 352 9131 854 865 9742977
   PubMed Web of Science ®Google Scholar
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) UK Prospective Diabetes Study (UKPDS) Group Lancet 1998 352 9131 837 853 9742976
   PubMed Web of Science ®Google Scholar
• Nathan DM Cleary PA Backlund JY Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N Engl J Med 2005 353 25 2643 2653 16371630
   PubMed Web of Science ®Google Scholar
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 UK Prospective Diabetes Study Group BMJ 1998 317 7160 703 713 9732337
   PubMed Web of Science ®Google Scholar
• Hansson L Zanchetti A Carruthers SG Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group Lancet 1998 351 9118 1755 1762 9635947
   PubMed Web of Science ®Google Scholar
• Colhoun HM Betteridge DJ Durrington PN Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial Lancet 2004 364 9435 685 696 15325833
   PubMed Web of Science ®Google Scholar
• Gaede P Vedel P Larsen N Jensen GV Parving HH Pedersen O Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 2003 348 5 383 393 12556541
   PubMed Web of Science ®Google Scholar
• Sacco M Pellegrini F Roncaglioni MC Avanzini F Tognoni G Nicolucci A Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial Diabetes Care 2003 26 12 3264 3272 14633812
   PubMed Web of Science ®Google Scholar
• American Diabetes Association Standards of medical care in diabetes– 2007 Diabetes Care 2007 30 Suppl 1 S4 S41 17192377
   PubMedGoogle Scholar
• Berenson GS Srinivasan SR Bao W Newman WP3rd Tracy RE Wattigney WA Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study N Engl J Med 1998 338 23 1650 1656 9614255
   PubMed Web of Science ®Google Scholar
• McGill HCJr McMahan CA Zieske AW Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group Arterioscler Thromb Vasc Biol 2000 20 8 1998 2004 10938023
   PubMed Web of Science ®Google Scholar
• Wiegman A Hutten BA de Groot E Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial JAMA 2004 292 3 331 337 15265847
   PubMed Web of Science ®Google Scholar
• McGill HCJr McMahan CA Gidding SS Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study Circulation 2008 117 9 1216 1227 18316498
   PubMed Web of Science ®Google Scholar
• Jarvisalo MJ Putto-Laurila A Jartti L Carotid artery intima-media thickness in children with type 1 diabetes Diabetes 2002 51 2 493 498 11812760
   PubMed Web of Science ®Google Scholar
• Krantz JS Mack WJ Hodis HN Liu CR Liu CH Kaufman FR Early onset of subclinical atherosclerosis in young persons with type 1 diabetes J Pediatr 2004 145 4 452 457 15480366
   PubMed Web of Science ®Google Scholar
• Morrison JA Friedman LA Harlan WR Development of the metabolic syndrome in black and white adolescent girls: a longitudinal assessment Pediatrics 2005 116 5 1178 1182 16264006
   PubMed Web of Science ®Google Scholar
• Anderson S Komers R Aliskiren combined with losartan in diabetes and nephropathy N Engl J Med 2008 359 10 1069 author reply 1069–1070 18777613
   PubMed Web of Science ®Google Scholar
• Lindner T Aliskiren combined with losartan in diabetes and nephropathy N Engl J Med 2008 359 10 1068 1069 author reply 1069–1070 18777612
   PubMed Web of Science ®Google Scholar
• Beaton SJ Nag SS Gunter MJ Gleeson JM Sajjan SS Alexander CM Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting Diabetes Care 2004 27 3 694 698 14988287
   PubMed Web of Science ®Google Scholar
• Bryant W Greenfield JR Chisholm DJ Campbell LV Diabetes guide-lines: easier to preach than to practise? Med J Aust 2006 185 6 305 309 16999670
   PubMed Web of Science ®Google Scholar
• Saydah SH Fradkin J Cowie CC Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes JAMA 2004 291 3 335 342 14734596
   PubMed Web of Science ®Google Scholar
• Schwab KO Doerfer J Hecker W Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV) Diabetes Care 2006 29 2 218 225 16443863
   PubMed Web of Science ®Google Scholar
• Wan Q Harris MF Jayasinghe UW Quality of diabetes care and coronary heart disease absolute risk in patients with type 2 diabetes mellitus in Australian general practice Qual Saf Health Care 2006 15 2 131 135 16585115
   PubMedGoogle Scholar
• Yong TY Phillipov G Phillips PJ Management outcomes of patients with type 2 diabetes: targeting the 10-year absolute risk of coronary heart disease Med J Aust 2007 186 12 622 624 17576176
   PubMed Web of Science ®Google Scholar
• NADC-ANDIAB (Australian National Diabetes Information Audit and Benchmarking) 2006 Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/73C7834F958FF73FCA2572B40000B5AC/$File/andiab06-all.pdf Accessed 2010 Sep 24
   Google Scholar
• Advance Collaborative Group http://www.ncbi.nlm.nih.gov/pubmed?term=%22Patel%20A%22%5BAuthor%5D Patel A MacMahon S Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 2008 358 24 2560 2572 18539916
   PubMed Web of Science ®Google Scholar
• Duckworth W Abraira C Moritz T Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 2009 360 2 129 139 19092145
   PubMed Web of Science ®Google Scholar
• Action to Control Cardiovascular Risk in Diabetes Study Group Gerstein HC Miller ME Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 2008 358 24 2545 2559 18539917
   PubMed Web of Science ®Google Scholar
• Holman RR Paul SK Bethel MA Matthews DR Neil HA 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 2008 359 15 1577 1589 18784090
   PubMed Web of Science ®Google Scholar
• Del Prato S Megatrials in type 2 diabetes. From excitement to frustration? Diabetologia 2009 52 7 1219 1226 19373446
   PubMed Web of Science ®Google Scholar
• Maahs DM Kinney GL Wadwa P Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population Diabetes Care 2005 28 2 301 306 15677783
   PubMed Web of Science ®Google Scholar
• Hatunic M Burns N Finucane F Mannion C Nolan JJ Contrasting clinical and cardiovascular risk status between early and later onset type 2 diabetes Diab Vasc Dis Res 2005 2 2 73 75 16305062
   PubMedGoogle Scholar
• McIntyre HD Marechal DJ Deby GP Mathieu AG Hezee-Hagelstein MT Franchimont PP Immunoreactive somatostatin in the rat ovary Acta Endocrinologica (Copenh) 1992 126 6 553 558
   Google Scholar
• Ogawa H Nakayama M Morimoto T Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial JAMA 2008 300 18 2134 2141 18997198
   PubMed Web of Science ®Google Scholar
• Kiortsis DN Giral P Bruckert E Turpin G Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients J Clin Pharm Ther 2000 25 6 445 451 11123498
   PubMed Web of Science ®Google Scholar
• Stewart SM Rao U White P Depression and diabetes in children and adolescents Curr Opin Pediatr 2005 17 5 626 631 16160538
   PubMed Web of Science ®Google Scholar
• Varma S Boyle LL Varma MR Piatt GA Controlling the ABCs of diabetes in clinical practice: a community-based endocrinology practice experience Diabetes Res Clin Pract 2008 80 1 89 95 18160171
   PubMed Web of Science ®Google Scholar